首页 › 基金 › TANAKA CAPITAL MANAGEMENT INC › CPRX
TANAKA CAPITAL MANAGEMENT INC 对 CPRX 的持仓历史
CATALYST PHARMACEUTICALS INC
TANAKA CAPITAL MANAGEMENT INC 在 Q1 2026 的 13F 申报中披露持有 CPRX(CATALYST PHARMACEUTICALS INC)113,418 股,市值约 US$2.8M,约占其申报组合的 4.69%,在其申报持仓中市值排名第 9 位。 TANAKA CAPITAL MANAGEMENT INC 最近 11 个申报季度中有 8 个季度披露了 CPRX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
TANAKA CAPITAL MANAGEMENT INC 对 CPRX 的持仓演变
TANAKA CAPITAL MANAGEMENT INC 于 Q3 2023 首次披露 CPRX 持仓:159,791 股(约 US$1.9M)。 该持仓在 Q1 2025 达到峰值 151,893 股,市值约 US$3.7M。 在 8 次申报中,TANAKA CAPITAL MANAGEMENT INC 0 次增持、5 次减持、2 次保持不变。 最近一期申报(Q1 2026)显示持股 113,418 股、市值约 US$2.8M,环比减持 -1,000 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 159.79K | $1.87M | 新进 |
| Q4 2023 | 154.43K | $2.60M | 减持 |
| Q3 2024 | 153.29K | $3.05M | 减持 |
| Q4 2024 | 153.29K | $3.20M | 持有 |
| Q1 2025 | 151.89K | $3.68M | 减持 |
| Q3 2025 | 114.42K | $2.25M | 减持 |
| Q4 2025 | 114.42K | $2.67M | 持有 |
| Q1 2026 | 113.42K | $2.81M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CPRX 与 13F 数据
CPRX(CATALYST PHARMACEUTICALS INC)的行业分类暂缺。我们追踪的基金中还有 43 只申报持有 CPRX,申报仓位最大的包括:GLAZER CAPITAL, LLC (US$113.2M), HBK INVESTMENTS L P (US$88.6M), NEXPOINT ASSET MANAGEMENT, L.P. (US$50.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CPRX 的基金
- GLAZER CAPITAL, LLC 3.60M 股 · $113.24M · Q2 2026
- HBK INVESTMENTS L P 2.82M 股 · $88.64M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 1.60M 股 · $50.37M · Q2 2026
- Polar Asset Management Partners Inc. 1.15M 股 · $36.15M · Q2 2026
- WATER ISLAND CAPITAL LLC 933.82K 股 · $29.35M · Q2 2026
- KENNEDY CAPITAL MANAGEMENT LLC 856.61K 股 · $26.92M · Q2 2026
- Sagefield Capital LP 569.48K 股 · $17.90M · Q2 2026
更多关于 TANAKA CAPITAL MANAGEMENT INC
常见问题
How long has TANAKA CAPITAL MANAGEMENT INC held CPRX?
TANAKA CAPITAL MANAGEMENT INC has disclosed CPRX holdings in 8 of the last 11 reported quarters, going back to Q3 2023.
What is TANAKA CAPITAL MANAGEMENT INC's current position in CPRX?
As of Q1 2026, TANAKA CAPITAL MANAGEMENT INC holds 113.42K shares of CPRX (CATALYST PHARMACEUTICALS INC), valued at $2.81M, representing 4.69% of its reported portfolio and ranking #9.
Has TANAKA CAPITAL MANAGEMENT INC been buying or selling CPRX?
In the latest 13F filing (Q1 2026), TANAKA CAPITAL MANAGEMENT INC reduced its position in CPRX. The position peaked in Q1 2025 at 151.89K shares.
Which other funds hold CPRX?
Other major institutional holders of CPRX include GLAZER CAPITAL, LLC, HBK INVESTMENTS L P, NEXPOINT ASSET MANAGEMENT, L.P., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.